Trans4orm

Trans4orm

Evlution Nutrition4.7 (2,118 ratings)
Format:Capsule Quantity: 120 Capsule(s) · 60 servings
Goals
$19.49 $0.32 per serving

Product analysis

56 out of 100

Trans4orm brings together a broad mix of active ingredients with their amounts listed. Several forms are unspecified, so it is less straightforward to assess than a simpler, more fully described formula.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality31

Assessed forms show uneven quality across the formula.

Ingredient Transparency80

Amounts and forms are not equally transparent, with omissions in the captured label.

Value For Money42

The assessed ingredients suggest limited value for the serving price.

Customer Satisfaction84

Customer feedback is generally positive, with the number of ratings providing context for that summary.

Product Focus63

The combination covers several actives; its fit depends on the goals evaluated in the supplied assessment.

Format
Capsule
Container
120 Capsule(s)
Per serving
$0.32
Customer rating
4.7 · 2,118 ratings
Report analysis

Goals

Metabolism Support
Impact
High effect
C- Ingredient FitC- PathwaysA EvidenceB+ Formulation Logic
Niacin · 15 mgVitamin B12 · 6 mcgVitamin B6 · 2 mgGreen Tea · 500 mgCaffeine · 175 mg

Caffeine can modestly and temporarily increase resting energy expenditure. The 175 mg per serving is a known caffeine amount, although a larger serving does not establish a proportionally greater effect. Green tea is present, but its unspecified preparation does not establish equivalence to the defined catechin mixtures studied. Yohimbe alongside caffeine adds blood-pressure and heart-rate load. These acute effects do not establish lasting weight or fat loss.

How this product is rated for Metabolism Support

Ingredient fit58

Caffeine and green tea provide the direct thermogenesis connection. The saved amount comparison also counts other ingredients whose normal metabolic roles do not prove a boost.
Goal fit
Other actives broaden the formula beyond this goal, reducing its focus.
Dose adequacy
The known amounts provide partial support in the saved comparison, without establishing a proven thermogenic dose.

Pathways55

The strongest saved functional coverage concerns adrenergic drive. That mechanism does not by itself establish greater whole-body energy expenditure.
Depth
The strongest saved contribution concerns adrenergic drive, with partial functional coverage.
Breadth
The saved findings cover adrenergic drive; other functions remain less supported.

Evidence93

Vitamin B12 is the strongest saved evidence contributor. Direct thermogenesis evidence is principally acute and does not establish durable weight loss.
Evidence strength
Vitamin B12 supplies the strongest saved evidence contribution; this does not override limitations in the direct energy-expenditure findings.
Studied preparation
The green tea preparation does not match a studied EGCG-graded extract.

Formulation logic83

The counted ingredients need no missing partner, but yohimbe alongside caffeine adds stimulant load and is flagged.
Partner coverage
The counted ingredients can contribute independently or have the required partner.
Conflicts
Yohimbe with caffeine is flagged for added blood-pressure and heart-rate load.
Effective doses
The counted amounts pass the saved minimum, which does not establish a proven increase in energy expenditure.
Study evidence
Caffeine Disputed 40 studies
Green Tea Supportive 31 studies
Niacin Supportive 17 studies
Vitamin B6 Supportive 16 studies
Weight Loss
Impact
Moderate effect
D Ingredient FitC- PathwaysB EvidenceB+ Formulation Logic
Green Tea · 500 mgCaffeine · 175 mg

175 mg of caffeine may temporarily increase heat production and energy expenditure. Habitual use can reduce its effects, and a short-term increase in calorie burning does not guarantee sustained weight loss. Green tea adds a possible catechin-related contribution, although weight findings vary by preparation. Caffeine combined with yohimbe raises a stimulant-stacking concern.

How this product is rated for Weight Loss

Ingredient fit48

Caffeine and green tea relate to the goal, but many other actives broaden the formula's focus. The saved findings give partial overall amount support to caffeine and green tea.
Goal fit
Caffeine and green tea relate to the goal, but many other actives broaden the formula's focus.
Dose adequacy
The saved findings give partial overall amount support to caffeine and green tea.

Pathways57

Heat production and energy expenditure are the strongest connection. Only heat production and energy expenditure reach the saved threshold for substantial coverage; other connections are weaker.
Depth
Heat production and energy expenditure are the strongest connection.
Breadth
Only heat production and energy expenditure reach the saved threshold for substantial coverage; other connections are weaker.

Evidence76

Green tea provides the strongest evidence contribution in the saved findings, with mixed, preparation-dependent weight findings. The saved findings recognize the preparations of the reviewed contributors at qualifying amounts.
Evidence strength
Green tea provides the strongest evidence contribution in the saved findings, with mixed, preparation-dependent weight findings.
Studied preparation
The saved findings recognize the preparations of the reviewed contributors at qualifying amounts.

Formulation logic83

Caffeine combined with yohimbe triggers the saved stimulant-stacking concern. All reviewed contributors meet the saved minimum amount threshold; that threshold is not a guarantee of weight loss.
Partner coverage
The reviewed contributors have no unmet partner requirement in the saved findings.
Conflicts
Caffeine combined with yohimbe triggers the saved stimulant-stacking concern.
Effective doses
All reviewed contributors meet the saved minimum amount threshold; that threshold is not a guarantee of weight loss.
Study evidence
Caffeine Disputed 14 studies
Green Tea Supportive 42 studies
Energy
Impact
High effect
B- Ingredient FitC- PathwaysA+ EvidenceA+ Formulation Logic
Vitamin B12 · 6 mcgCaffeine · 175 mg

Caffeine promotes alertness and reduces sleepiness, making it the clearest immediate energy contribution here. The explicitly declared 175 mg per serving supports that role; botanical mass does not establish additional caffeine. Niacin, folate and B6 support nutritional adequacy, with fatigue benefits tied to low intake. The supplied tyrosine and B12 amounts do not count in the saved finding, and extra nutrient intake does not establish added energy when intake is adequate.

How this product is rated for Energy

Ingredient fit71

Caffeine and three nutrients contribute, alongside ingredients aimed at other goals. Tyrosine and B12 are below the saved inclusion thresholds.
Goal fit
Caffeine and three nutrients contribute, alongside ingredients aimed at other goals. Tyrosine and B12 are below the saved inclusion thresholds.
Dose adequacy
The declared caffeine and nutrient amounts contribute, while the smaller tyrosine and B12 amounts are excluded.

Pathways57

Caffeine provides substantial coverage of alertness, with no other energy route covered.
Depth
The strongest covered route is alertness.
Breadth
Only this single route reaches the required coverage level.

Evidence100

Caffeine leads the evidence finding, and the four included ingredients match studied preparations.
Evidence strength
Caffeine leads the saved evidence finding, subject to the specific limitations described above.
Studied preparation
Caffeine leads the evidence finding, and the four included ingredients match studied preparations.

Formulation logic100

The included ingredients do not require an unmet partner, and no configured conflict was detected.
Partner coverage
No required partner is missing for the included ingredients.
Conflicts
No configured ingredient conflict was detected.
Effective doses
All 4 included ingredients meet the saved minimum amount threshold; that threshold does not prove fatigue relief.
Study evidence
Caffeine Supportive 68 studies
Cognitive Support
Impact
Highest effect
B Ingredient FitB PathwaysA+ EvidenceA Formulation Logic
Choline · 300 mgVitamin B6 · 2 mgFolate · 400 mcgVitamin B12 · 6 mcgGreen Tea · 500 mgAlpha-GPC · 50 mg

Caffeine supports alertness and sustained attention, with no consistent memory or learning improvement and potential tolerance in habitual users. Niacin and folate may help when low intake affects cognition. Yohimbe introduces a concern because its stimulant amines can increase anxiety and heart rate without cognitive benefit. The smaller choline, Alpha-GPC, tyrosine and B12 amounts did not contribute in the saved comparison.

How this product is rated for Cognitive Support

Ingredient fit76

Cognitive ingredients sit within a broader formula containing ingredients aimed at other uses. Most counted amounts approach the comparison amounts, without establishing that they reproduce trial benefits.
Goal fit
Cognitive ingredients sit within a broader formula containing ingredients aimed at other uses.
Dose adequacy
Most counted amounts approach the comparison amounts, without establishing that they reproduce trial benefits.

Pathways79

The strongest assigned connection concerns oxidative and inflammatory protection, without proving improved cognitive performance. Two mechanisms reach the required coverage level; this describes ingredient connections rather than the breadth of proven benefits.
Depth
The strongest assigned connection concerns oxidative and inflammatory protection, without proving improved cognitive performance.
Breadth
Two mechanisms reach the required coverage level; this describes ingredient connections rather than the breadth of proven benefits.

Evidence100

Vitamin B6 leads the saved evidence comparison, but its specific population and outcome limitations still apply.
Evidence strength
Vitamin B6 leads the saved evidence comparison, but its specific population and outcome limitations still apply.
Studied preparation
The counted preparations were treated as matching the comparison; this does not remove the ingredient-specific evidence limitations.

Formulation logic93

Yohimbe introduces a stimulant-amine conflict despite the counted ingredients meeting the amount and partner comparisons.
Partner coverage
No counted ingredient was missing a required partner; this does not establish an added benefit from combining ingredients.
Conflicts
Yohimbe triggered the stimulant-amine concern because these compounds can raise anxiety and heart rate without cognitive benefit.
Effective doses
All counted ingredients exceed the minimum comparison amount, which is not a proven effective-dose threshold.
Study evidence
Alpha-GPC Supportive 15 studies
Choline Supportive 76 studies
Folate Supportive 68 studies
Green Tea Supportive 32 studies
Vitamin B6 Supportive 17 studies
Mental Focus
Impact
High effect
B Ingredient FitC PathwaysB EvidenceA Formulation Logic
Choline · 300 mgFolate · 400 mcgVitamin B6 · 2 mgVitamin B12 · 6 mcgAlpha-GPC · 50 mgCaffeine · 175 mg

Caffeine can improve short-term alertness, vigilance and attention-task performance. Timing, habitual use and sleep loss can change its practical effect. Vitamin B12 and the included B vitamins can help address low intake that impairs concentration; extra focus with adequate intake is not established. Yohimbe may increase anxiety and work against the intended focus benefit.

How this product is rated for Mental Focus

Ingredient fit79

The included amounts partly match the supplied comparisons, with low or undisclosed amounts limiting some contributions.
Goal fit
Several ingredients serve other purposes, giving the formula a broader focus than acute attention.
Dose adequacy
The included amounts partly match the supplied comparisons, with low or undisclosed amounts limiting some contributions.

Pathways60

The strongest saved connection concerns adenosine-blocking alertness; a mechanism-related finding does not establish broad attention improvement.
Depth
The strongest saved connection concerns adenosine-blocking alertness; a mechanism-related finding does not establish broad attention improvement.
Breadth
Coverage centers on one mechanism, leaving the other focus-related routes unrepresented.

Evidence79

Caffeine has direct acute attention and vigilance findings, with individual response and circumstances affecting relevance.
Evidence strength
Caffeine has direct acute attention and vigilance findings, with individual response and circumstances affecting relevance.
Studied preparation
The saved findings recognize the included preparations, without proving superior delivery or broad focus benefits.

Formulation logic93

No required partner is missing in the supplied findings; this does not establish synergy. Yohimbe may increase anxiety and work against the intended focus benefit.
Partner coverage
No required partner is missing in the supplied findings; this does not establish synergy.
Conflicts
Yohimbe may increase anxiety and work against the intended focus benefit.
Effective doses
All retained ingredients pass the minimum amount comparison, which is not proof of an effective clinical dose.
Study evidence
Alpha-GPC Supportive 1 study
Caffeine Supportive 128 studies
Choline Supportive 22 studies
Folate Mixed 12 studies
Fitness
Impact
Moderate effect
D Ingredient FitC- PathwaysB EvidenceA+ Formulation Logic
Caffeine · 175 mg

Caffeine at 175 mg may support exercise performance by increasing central drive and reducing perceived fatigue, with the clearest evidence for endurance. Strength and sprint effects vary, and the fixed serving amount is not a personal body-weight-based dose.

How this product is rated for Fitness

Ingredient fit49

The relevant ingredients form part of a broader formula with other nutritional or health roles. The assessed amount is close to the full comparison exposure.
Goal fit
The relevant ingredients form part of a broader formula with other nutritional or health roles.
Dose adequacy
The assessed amount is close to the full comparison exposure.

Pathways55

The strongest contribution concerns central drive and perceived fatigue. One assessed pathway reaches substantial coverage, so support remains focused.
Depth
The strongest contribution concerns central drive and perceived fatigue.
Breadth
One assessed pathway reaches substantial coverage, so support remains focused.

Evidence77

Caffeine provides the strongest assessed evidence at an eligible amount. The supplied population and exercise-context limits still apply. The included preparations match those recognized in the saved findings.
Evidence strength
Caffeine provides the strongest assessed evidence at an eligible amount. The supplied population and exercise-context limits still apply.
Studied preparation
The included preparations match those recognized in the saved findings.

Formulation logic100

The assessed ingredients work alone or have their required partner. No configured ingredient conflict was identified. 1 of 1 assessed ingredients meet the saved minimum exposure threshold. That threshold does not guarantee better performance.
Partner coverage
The assessed ingredients work alone or have their required partner.
Conflicts
No configured ingredient conflict was identified.
Effective doses
1 of 1 assessed ingredients meet the saved minimum exposure threshold. That threshold does not guarantee better performance.
Study evidence
Caffeine Supportive 255 studies
Productivity Boost
Impact
High effect
B Ingredient FitC PathwaysB EvidenceB+ Formulation Logic
Vitamin B12 · 6 mcgVitamin B12 · 6 mcgVitamin B6 · 2 mgAlpha-GPC · 50 mgCaffeine · 175 mg

Caffeine provides the clearest connection to short term alertness and attention. Folate can address fatigue and concentration problems associated with deficiency, while the small Alpha-GPC amount was not counted. The formula also contains a sympathomimetic stimulant, which creates a conflict because these stimulants can raise anxiety, blood pressure and heart rate without an established attention benefit.

How this product is rated for Productivity Boost

Ingredient fit76

Attention related ingredients provide the main goal connection, with the saved amount and focus findings limiting how broadly to interpret it.
Goal fit
The relevant ingredients share the formula with other actives, making its focus on this goal less concentrated.
Dose adequacy
The recognized ingredients have fully disclosed amounts that meet the saved comparison’s amount criteria.

Pathways60

Support is concentrated in the main attention or alertness pathway, rather than spread broadly across memory, energy and stress mechanisms.
Depth
Caffeine supplies the strongest pathway contribution through adenosine blocking alertness.
Breadth
Only the main attention or alertness pathway reaches the saved coverage threshold; broader support remains limited.

Evidence76

The strongest evidence concerns attention task outcomes. The saved preparation finding must be read alongside the ingredient specific limitations.
Evidence strength
Caffeine sets the strongest saved evidence finding; the relevant cognitive task findings do not establish sustained work output.
Studied preparation
The saved result recognizes the qualifying preparations; that designation does not establish superior work performance.

Formulation logic83

Required partners are covered, but a configured ingredient conflict limits the formulation’s fit for daytime productivity.
Partner coverage
No required ingredient partner is missing from the recognized contributions; this does not establish an added combination benefit.
Conflicts
The sympathomimetic stimulant creates a conflict through anxiety, blood pressure and heart rate effects without established attention benefit.
Effective doses
All recognized contributors meet the saved minimum amount criterion; this is not a proven clinical effectiveness threshold.
Study evidence
Alpha-GPC Supportive 2 studies
Caffeine Supportive 108 studies

Ingredients

IngredientAmount per servingScore
Niacin (Vitamin B3)
15 mg
Vitamin B6 (Pyridoxine Hydrochloride)
2 mg
Folic Acid
400 mcg 54
Vitamin B12 (Methylcobalamin)
6 mcg
Choline
120 mg 56
Green Tea leaf extract
500 mg 24
Choline Bitartrate
300 mg 56
L-Tyrosine
200 mg 56
natural Caffeine (Coffee)
175 mg 68
Coleus extract
100 mg
Alpha-Glycerolphosphorylcholine powder (Alpha-GPC)
50 mg 25
Yohimbe extract
20 mg
Black Pepper extract
5 mg
Huperzia serrata extract (Huperzine A)
2 mg
Gluten Free Adults 18–50
Report overview
Choline · 120 mg OverallScore56
D+ Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyF Value
Each serving provides 120 mg choline from choline bitartrate, a moderate amount. The evaluation flags additives, and the price is about $0.27 per 100 mg of choline.
How this ingredient is rated

Active Ingredient Quality & Bioavailability53

Choline bitartrate is a standard choline form used for systemic support. The evaluation flags additives in the product.
Choline Form Efficacy & Bioavailability
Choline bitartrate is a standard choline form used for systemic support.
Formula Purity & Excipient Quality
The evaluation flags additives in the product.

Dose, Safety & Label Transparency77

Each serving supplies 120 mg choline, a moderate amount in the evaluation. The amount and source are disclosed.
Choline Dose by Declared Basis
Each serving supplies 120 mg choline, a moderate amount in the evaluation.
Elemental Yield Transparency
The choline amount and its source are both recorded: 120 mg choline from choline bitartrate.

Value20

The price works out to about $0.27 per 100 mg of choline, relatively high in the evaluation.
Price per 100 mg of Declared Choline Basis
The price works out to about $0.27 per 100 mg of choline, relatively high in the evaluation.
D- Active Ingredient Quality & BioavailabilityA Dose, Safety & Label TransparencyB+ Value
A serving provides 175 mg of caffeine along with another stimulant. The saved facts do not establish the other stimulant’s amount, which makes the combined stimulant load harder to judge.
How this ingredient is rated

Active Ingredient Quality & Bioavailability40

The evaluation recognizes an identified caffeine source, but the saved form details do not specify which form.
Advanced Bioavailability and Release Profiles
The evaluation recognizes an identified caffeine source, but the saved form details do not specify which form.

Dose, Safety & Label Transparency90

A serving provides 175 mg of caffeine. Another stimulant is recorded, but its amount is not established in the saved facts.
Caffeine Dose Transparency
The caffeine amount is recorded as 175 mg per serving.
Dosage Efficacy and Safety Margin
A serving provides 175 mg of caffeine.
Secondary Stimulant Disclosure and Risk
Another stimulant is recorded, but its amount is not established in the saved facts.

Value80

A whole-product serving costs about $0.32.
Price Per Serving vs. Collection Median
A whole-product serving costs about $0.32.
Tyrosine · 200 mg OverallScore56
A- Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value
A serving supplies 200 mg of L-tyrosine. The whole-product price works out to about $1.62 per gram of tyrosine.
How this ingredient is rated

Active Ingredient Quality & Bioavailability85

The recorded form is L-tyrosine, with a GMP manufacturing claim in the saved facts.
Tyrosine Chemical Form
The recorded form is L-tyrosine.
Purity and Sourcing Signals
The saved facts record GMP-certified manufacturing but do not give specific tyrosine purity data.

Dose, Safety & Label Transparency51

A serving supplies 200 mg of L-tyrosine.
Tyrosine Dosage Adequacy
The 200 mg per serving is rated as a relatively modest amount for cognitive support.
Label Transparency and Blends
The amount of tyrosine is recorded individually as 200 mg per serving.

Value10

The whole-product price works out to about $1.62 per gram of tyrosine.
Price per Gram of Tyrosine
The whole-product price works out to about $1.62 per gram of tyrosine.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M · Medicine · 2024
    Randomized trial119 participantsCognitive Support forAlpha-GPC
  2. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    Sagaro GG; Traini E; Amenta F · Journal of Alzheimer's disease : JAD · 2023
    Meta-analysis8 studies pooledCognitive Support forAlpha-GPC
  3. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsCognitive Support forAlpha-GPC Cognitive Support forCholine
  4. [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
    Voznyuk IA; Nepomnyashchiy IS; Kutkova AK; Tokareva DV; Prokhorova MV; Ovdiienko OA; Shusharina NN · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2025
    Meta-analysis10 studies pooledCognitive Support forAlpha-GPC
  5. Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
    Guan F; Jia X; Huang F; Zhang J; Wei Y; Li L; Bai J; Wang H · Nutrients · 2024
    Cohort study7,659 participantsCognitive Support forAlpha-GPC
  6. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsCognitive Support forCholine
  7. Association of dietary choline intake with incidence of dementia, Alzheimer disease, and mild cognitive impairment: a large population-based prospective cohort study.
    Niu YY; Yan HY; Zhong JF; Diao ZQ; Li J; Li CP; Chen LH; Huang WQ; Xu M; Xu ZT; Liang XF; Li ZH; Liu D · The American journal of clinical nutrition · 2025
    Cohort study125,594 participantsCognitive Support forCholine
  8. Choline intake during pregnancy and child cognition at age 7 years.
    Boeke CE; Gillman MW; Hughes MD; Rifas-Shiman SL; Villamor E; Oken E · American journal of epidemiology · 2013
    Cohort study895 participantsCognitive Support forCholine
  9. Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes.
    Warton FL; Molteno CD; Warton CMR; Wintermark P; Lindinger NM; Dodge NC; Zöllei L; van der Kouwe AJW; Carter RC; Jacobson JL; Jacobson SW; Meintjes EM · Alcoholism, clinical and experimental research · 2022
    Randomized trial52 participantsCognitive Support forCholine
  10. Effects of 6-Month Folic Acid Supplementation on Cognitive Function and Blood Biomarkers in Mild Cognitive Impairment: A Randomized Controlled Trial in China.
    Ma F; Wu T; Zhao J; Han F; Marseglia A; Liu H; Huang G · The journals of gerontology. Series A, Biological sciences and medical sciences · 2017
    Randomized trial180 participantsCognitive Support forFolate
  11. Serum folate and B12 levels in association with cognitive impairment among seniors: results from the VELESTINO study in Greece and meta-analysis.
    Michelakos T; Kousoulis AA; Katsiardanis K; Dessypris N; Anastasiou A; Katsiardani KP; Kanavidis P; Stefanadis C; Papadopoulos FC; Petridou ET · Journal of aging and health · 2013
    Meta-analysis8,122 participants9 studies pooledCognitive Support forFolate
  12. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis.
    Wang Z; Zhu W; Xing Y; Jia J; Tang Y · Nutrition reviews · 2022
    Meta-analysis46,175 participants95 studies pooledCognitive Support forFolate
  13. Homocysteine and folate as risk factors for dementia and Alzheimer disease.
    Ravaglia G; Forti P; Maioli F; Martelli M; Servadei L; Brunetti N; Porcellini E; Licastro F · The American journal of clinical nutrition · 2005
    Cohort study816 participantsCognitive Support forFolate
  14. Folate mediates cognitive impairment of aged people with periodontitis.
    Liu F; Liu Y; Feng Y; Zhao J; Wang M; Ye M; Zhang Y; Gan X; Pan Q; Shen J · Nutritional neuroscience · 2025
    Cross-sectional study1,966 participantsCognitive Support forFolate
  15. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
    de la Torre R; de Sola S; Hernandez G; Farré M; Pujol J; Rodriguez J; Espadaler JM; Langohr K; Cuenca-Royo A; Principe A; Xicota L; Janel N; Catuara-Solarz S; Sanchez-Benavides G; Bléhaut H; Dueñas-Espín I; Del Hoyo L; Benejam B; Blanco-Hinojo L; Videla S; Fitó M; Delabar JM; Dierssen M; TESDAD study group · The Lancet. Neurology · 2017
    Randomized trial87 participantsCognitive Support forGreen Tea
  16. Association between tea consumption and risk of cognitive disorders: A dose-response meta-analysis of observational studies.
    Liu X; Du X; Han G; Gao W · Oncotarget · 2018
    Meta-analysis48,435 participants17 studies pooledCognitive Support forGreen Tea
  17. Investigating the Impact of Tea Consumption on Cognitive Function and Exploring Tea-Genetic Interactions in Older Adults Aged 65-105 Years: Findings from the 2002-2018 CLHLS Data.
    Yu L; Yang M; Ye KX; Li C; Zou M; Wang J; Yuan X; Zheng D; Sun C; Zhang Y; Feng Q; Maier AB; Sun L; Feng L; Wang Y; Chen H; Zeng Y · The journal of prevention of Alzheimer's disease · 2024
    Cohort study76,270 participantsCognitive Support forGreen Tea
  18. Consumption of green tea, but not black tea or coffee, is associated with reduced risk of cognitive decline.
    Noguchi-Shinohara M; Yuki S; Dohmoto C; Ikeda Y; Samuraki M; Iwasa K; Yokogawa M; Asai K; Komai K; Nakamura H; Yamada M · PloS one · 2014
    Cohort study490 participantsCognitive Support forGreen Tea
  19. Green Tea Consumption and the Risk of Incident Dementia in Elderly Japanese: The Ohsaki Cohort 2006 Study.
    Tomata Y; Sugiyama K; Kaiho Y; Honkura K; Watanabe T; Zhang S; Sugawara Y; Tsuji I · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2018
    Cohort study13,645 participantsCognitive Support forGreen Tea
  20. Maternal Vitamin B12 Status During Pregnancy and Its Association With Outcomes of Pregnancy and Health of the Offspring: A Systematic Review and Implications for Policy in India.
    Behere RV; Deshmukh AS; Otiv S; Gupte MD; Yajnik CS · Frontiers in endocrinology · 2021
    Systematic review46 studies pooledCognitive Support forVitamin B12